Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Matthews

Showing results (181-190 of 293) with videos related to

Pageof 30
Sort By:
Virology Journal|February 26, 2016
Alanine aminotransferase, HCV RNA levels and pro-inflammatory and pro-fibrogenic cytokines/chemokines during acute hepatitis C virus infectionBehzad Hajarizadeh, François Mj Lamoury, Jordan J Feld, et al.
JHEP Reports : Innovation in Hepatology|March 14, 2024
Corrigendum to "Trends in decompensated cirrhosis and hepatocellular carcinoma among people with a hepatitis B notification in New South Wales" [JHEP Reports 4 (2022)]Syed Hassan Bin Usman Shah, Maryam Alavi, Behzad Hajarizadeh, et al.
Journal of Hepatology|September 15, 2020
High hepatitis C treatment uptake among people with recent drug dependence in New South Wales, AustraliaHeather Valerio, Maryam Alavi, Matthew Law, et al.
AIDS (London, England)|May 5, 2012
Virological responses during treatment for recent hepatitis C virus: potential benefit for ribavirin use in HCV/HIV co-infectionJason Grebely, Margaret Hellard, Tanya Applegate, et al.
AIDS (London, England)|July 9, 2009
Combination HBV therapy is linked to greater HBV DNA suppression in a cohort of lamivudine-experienced HIV/HBV coinfected individualsGail V Matthews, Eric Seaberg, Gregory J Dore, et al.
Hepatology (Baltimore, Md.)|October 28, 2011
Hepatitis C virus reinfection and superinfection among treated and untreated participants with recent infectionJason Grebely, Son Truong Pham, Gail V Matthews, et al.
Plos One|April 18, 2013
Quantitative HBsAg and HBeAg predict hepatitis B seroconversion after initiation of HAART in HIV-HBV coinfected individualsGail V Matthews, Rachel J Ali, Anchalee Avihingsanon, et al.
Communicable Diseases Intelligence (2018)|November 15, 2023
The APPRISE Virtual Biobank for Infectious DiseasesMiranda Z Smith, Maureen Turner, Javier Haurat, et al.
Plos One|November 27, 2013
Plasma interferon-gamma-inducible protein-10 levels are associated with early, but not sustained virological response during treatment of acute or early chronic HCV infectionJordan J Feld, Jason Grebely, Gail V Matthews, et al.
AIDS Research and Human Retroviruses|March 9, 2022
High Proportion of Blood-Borne and Sexually Transmitted Infections Among People Deprived of Liberty in a Central Male Prison in Thailand: A Cross-Sectional Study 2018-2019Weerakit Harnpariphan, Win Min Han, Ruamthip Supanun, et al.
Pageof 30

Showing results (181-190 of 293) with videos related to

Sort By:
Pageof 30
Virology Journal|February 26, 2016
Alanine aminotransferase, HCV RNA levels and pro-inflammatory and pro-fibrogenic cytokines/chemokines during acute hepatitis C virus infectionBehzad Hajarizadeh, François Mj Lamoury, Jordan J Feld, et al.
JHEP Reports : Innovation in Hepatology|March 14, 2024
Corrigendum to "Trends in decompensated cirrhosis and hepatocellular carcinoma among people with a hepatitis B notification in New South Wales" [JHEP Reports 4 (2022)]Syed Hassan Bin Usman Shah, Maryam Alavi, Behzad Hajarizadeh, et al.
Journal of Hepatology|September 15, 2020
High hepatitis C treatment uptake among people with recent drug dependence in New South Wales, AustraliaHeather Valerio, Maryam Alavi, Matthew Law, et al.
AIDS (London, England)|May 5, 2012
Virological responses during treatment for recent hepatitis C virus: potential benefit for ribavirin use in HCV/HIV co-infectionJason Grebely, Margaret Hellard, Tanya Applegate, et al.
AIDS (London, England)|July 9, 2009
Combination HBV therapy is linked to greater HBV DNA suppression in a cohort of lamivudine-experienced HIV/HBV coinfected individualsGail V Matthews, Eric Seaberg, Gregory J Dore, et al.
Hepatology (Baltimore, Md.)|October 28, 2011
Hepatitis C virus reinfection and superinfection among treated and untreated participants with recent infectionJason Grebely, Son Truong Pham, Gail V Matthews, et al.
Plos One|April 18, 2013
Quantitative HBsAg and HBeAg predict hepatitis B seroconversion after initiation of HAART in HIV-HBV coinfected individualsGail V Matthews, Rachel J Ali, Anchalee Avihingsanon, et al.
Communicable Diseases Intelligence (2018)|November 15, 2023
The APPRISE Virtual Biobank for Infectious DiseasesMiranda Z Smith, Maureen Turner, Javier Haurat, et al.
Plos One|November 27, 2013
Plasma interferon-gamma-inducible protein-10 levels are associated with early, but not sustained virological response during treatment of acute or early chronic HCV infectionJordan J Feld, Jason Grebely, Gail V Matthews, et al.
AIDS Research and Human Retroviruses|March 9, 2022
High Proportion of Blood-Borne and Sexually Transmitted Infections Among People Deprived of Liberty in a Central Male Prison in Thailand: A Cross-Sectional Study 2018-2019Weerakit Harnpariphan, Win Min Han, Ruamthip Supanun, et al.
Pageof 30